药品注册申请号:017060
申请类型:NDA (新药申请)
申请人:TEVA BRANDED PHARM
申请人全名:TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 NOR-QD NORETHINDRONE TABLET;ORAL-28 0.35MG Yes Yes AB1 1973/01/02 Approved Prior to Jan 1, 1982 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2015/12/03 SUPPL-83(补充) Approval Manufacturing (CMC) STANDARD
2015/10/09 SUPPL-82(补充) Approval Manufacturing (CMC) STANDARD
2012/12/17 SUPPL-81(补充) Approval Manufacturing (CMC) STANDARD
2005/10/20 SUPPL-67(补充) Approval Labeling STANDARD
1999/11/30 SUPPL-64(补充) Approval Labeling STANDARD
1999/09/30 SUPPL-66(补充) Approval Manufacturing (CMC) STANDARD
1999/02/24 SUPPL-65(补充) Approval Manufacturing (CMC) STANDARD
1996/12/11 SUPPL-63(补充) Approval Labeling STANDARD
1995/05/26 SUPPL-61(补充) Approval Labeling STANDARD
1995/05/23 SUPPL-62(补充) Approval Labeling STANDARD
1990/11/02 SUPPL-58(补充) Approval Labeling
1990/09/19 SUPPL-59(补充) Approval Manufacturing (CMC) STANDARD
1986/10/22 SUPPL-56(补充) Approval Labeling
1985/10/25 SUPPL-55(补充) Approval Labeling
1985/06/19 SUPPL-54(补充) Approval Labeling
1984/11/13 SUPPL-52(补充) Approval Manufacturing (CMC) STANDARD
1984/09/27 SUPPL-50(补充) Approval Manufacturing (CMC) STANDARD
1984/06/12 SUPPL-51(补充) Approval Labeling
1984/03/28 SUPPL-46(补充) Approval Labeling
1983/07/26 SUPPL-49(补充) Approval Manufacturing (CMC) STANDARD
1983/07/26 SUPPL-45(补充) Approval Manufacturing (CMC) STANDARD
1983/07/19 SUPPL-48(补充) Approval Manufacturing (CMC) STANDARD
1983/07/19 SUPPL-47(补充) Approval Manufacturing (CMC) STANDARD
1983/06/13 SUPPL-44(补充) Approval Manufacturing (CMC) STANDARD
1982/07/29 SUPPL-41(补充) Approval Manufacturing (CMC) STANDARD
1981/01/02 SUPPL-16(补充) Approval Labeling
1980/05/20 SUPPL-37(补充) Approval Manufacturing (CMC) STANDARD
1979/07/18 SUPPL-36(补充) Approval Manufacturing (CMC) STANDARD
1979/07/18 SUPPL-33(补充) Approval Manufacturing (CMC) STANDARD
1978/11/06 SUPPL-29(补充) Approval Manufacturing (CMC) STANDARD
1978/11/06 SUPPL-28(补充) Approval Manufacturing (CMC) STANDARD
1978/05/26 SUPPL-27(补充) Approval Manufacturing (CMC) STANDARD
1977/07/01 SUPPL-18(补充) Approval Labeling
1977/07/01 SUPPL-17(补充) Approval Labeling
1976/06/25 SUPPL-13(补充) Approval Manufacturing (CMC) STANDARD
1975/05/16 SUPPL-10(补充) Approval Labeling
1975/05/16 SUPPL-8(补充) Approval Manufacturing (CMC) STANDARD
1975/05/16 SUPPL-6(补充) Approval Manufacturing (CMC) STANDARD
1973/01/02 ORIG-1(原始申请) Approval Type 3 - New Dosage Form STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:NORETHINDRONE 剂型/给药途径:TABLET;ORAL-28 规格:0.35MG 治疗等效代码:AB1
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
017060 001 NDA NOR-QD NORETHINDRONE TABLET;ORAL-28 0.35MG Prescription Yes Yes AB1 Approved Prior to Jan 1, 1982 TEVA BRANDED PHARM
076177 001 ANDA CAMILA NORETHINDRONE TABLET;ORAL-28 0.35MG Prescription No No AB1 2002/10/21 DR REDDYS LABS SA
090454 001 ANDA HEATHER NORETHINDRONE TABLET;ORAL-28 0.35MG Prescription No No AB1 2010/04/23 GLENMARK PHARMS LTD
091325 001 ANDA NORETHINDRONE NORETHINDRONE TABLET;ORAL-28 0.35MG Prescription No No AB1 2011/09/19 LUPIN LTD
201483 001 ANDA NORETHINDRONE NORETHINDRONE TABLET;ORAL-28 0.35MG Prescription No No AB1 2013/06/24 MYLAN LABS LTD
202260 001 ANDA NORETHINDRONE NORETHINDRONE TABLET;ORAL-28 0.35MG Discontinued No No AB1 2013/08/01 AMNEAL PHARMS
202014 001 ANDA NORETHINDRONE NORETHINDRONE TABLET;ORAL-28 0.35MG Prescription No No AB1 2013/09/13 NOVAST LABS
207304 001 ANDA INCASSIA NORETHINDRONE TABLET;ORAL-28 0.35MG Prescription No No AB1 2016/09/23 AUROBINDO PHARMA
206807 001 ANDA NORETHINDRONE NORETHINDRONE TABLET;ORAL-28 0.35MG Prescription No No AB1 2016/12/13 NAARI PTE LTD
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database